New York Life Investment Management’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103M Buy
1,446,949
+307,716
+27% +$21.4M 0.72% 26
2026
Q1
$73M Sell
1,139,233
-126,704
-10% -$8.36M 0.62% 30
2025
Q4
$79.1M Buy
1,265,937
+161,275
+15% +$9.88M 0.68% 26
2025
Q3
$66.2M Sell
1,104,662
-252,613
-19% -$14.7M 0.58% 28
2025
Q2
$77.4M Buy
1,357,275
+665,945
+96% +$35.7M 0.72% 25
2025
Q1
$35.1M Buy
691,330
+68,728
+11% +$3.48M 0.36% 50
2024
Q4
$29.8M Sell
622,602
-24,568
-4% -$1.23M 0.29% 61
2024
Q3
$34.2M Buy
647,170
+185,494
+40% +$9.43M 0.33% 53
2024
Q2
$22.8M Buy
461,676
+442,649
+2,326% +$22M 0.23% 79
2024
Q1
$955K Buy
+19,027
New +$919K 0.01% 682
2023
Q2
Sell
-293,949
Closed -$13.3M 1356
2023
Q1
$13.3M Sell
293,949
-209,053
-42% -$9.31M 0.15% 150
2022
Q4
$21.1M Sell
503,002
-30,076
-6% -$1.22M 0.24% 92
2022
Q3
$19.4M Sell
533,078
-220,932
-29% -$9M 0.23% 87
2022
Q2
$30.8M Buy
+754,010
New +$33.5M 0.36% 48
2016
Q3
Sell
-114,917
Closed -$4.06M 52
2016
Q2
$4.06M Sell
114,917
-3,100
-3% -$112K 0.45% 33
2016
Q1
$4.23M Buy
118,017
+6,900
+6% +$238K 0.63% 35
2015
Q4
$4.08M Buy
111,117
+1,300
+1% +$48.8K 0.61% 37
2015
Q3
$3.91M Buy
109,817
+7,500
+7% +$288K 0.37% 58
2015
Q2
$4.06M Sell
102,317
-4,600
-4% -$190K 0.46% 54
2015
Q1
$4.26M Sell
106,917
-100
-0.1% -$3.92K 0.48% 50
2014
Q4
$4.05M Buy
107,017
+8,900
+9% +$345K 0.49% 55
2014
Q3
$3.9M Buy
98,117
+5,300
+6% +$221K 0.64% 42
2014
Q2
$3.95M Sell
92,817
-800
-0.9% -$33.7K 0.67% 42
2014
Q1
$3.86M Buy
93,617
+100
+0.1% +$4.1K 0.82% 33
2013
Q4
$3.9M Buy
93,517
+100
+0.1% +$4.06K 0.97% 36
2013
Q3
$3.7M Sell
93,417
-6,300
-6% -$240K 1.14% 31
2013
Q2
$3.55M Buy
+99,717
New +$3.73M 1.13% 26

Other funds holding VEA

New York Life Investment Management's VEA Position: Q2 2026 in Review

New York Life Investment Management increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 27% in Q2 2026, buying an estimated $21.4M and bringing the position to 1,446,949 shares worth $103M. The position accounts for 0.72% of the portfolio, ranked #26.

New York Life Investment Management first reported a position in VEA in Q2 2013 and has held it in 27 quarters since. 2,989 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

  • New York Life Investment Management held 1,446,949 shares of Vanguard FTSE Developed Markets ETF worth $103M as of Q2 2026.
  • New York Life Investment Management bought 307,716 Vanguard FTSE Developed Markets ETF shares in Q2 2026, an estimated $21.4M.
  • Vanguard FTSE Developed Markets ETF made up 0.72% of New York Life Investment Management's portfolio in Q2 2026, its #26 holding.
  • New York Life Investment Management first reported a position in Vanguard FTSE Developed Markets ETF in Q2 2013 and has held it in 27 quarters since.
  • 2,989 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.